Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Jean-Philippe

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The Lancet. HIV|November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept studyTheodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2025
Long-term clinical, immunologic, and viral reservoir outcomes in children treated with VRC01LS and 10-1074 monoclonal antibodies in the Tatelo StudyGbolahan Ajibola, Bryan S Nelson, Aischa Niesar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2024
Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trialMarley D Bishop, Violet Korutaro, Ceejay L Boyce, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of LifeBryan S Nelson, Camlin Tierney, Deborah Persaud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2019
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency VirusMichael J Boivin, Miriam Chernoff, Lee Fairlie, et al.
The Journal of Infectious Diseases|February 2, 2020
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The New England Journal of Medicine|October 15, 2010
Antiretroviral treatment for children with peripartum nevirapine exposurePaul Palumbo, Jane C Lindsey, Michael D Hughes, et al.
Lancet (London, England)|November 12, 2013
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trialMark F Cotton, Avy Violari, Kennedy Otwombe, et al.
Science Translational Medicine|November 29, 2019
Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profilePilar Garcia-Broncano, Shivaali Maddali, Kevin B Einkauf, et al.
The American Journal of Tropical Medicine and Hygiene|November 23, 2017
Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral TherapyCharlotte V Hobbs, Erin E Gabriel, Portia Kamthunzi, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The Lancet. HIV|November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept studyTheodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2025
Long-term clinical, immunologic, and viral reservoir outcomes in children treated with VRC01LS and 10-1074 monoclonal antibodies in the Tatelo StudyGbolahan Ajibola, Bryan S Nelson, Aischa Niesar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2024
Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trialMarley D Bishop, Violet Korutaro, Ceejay L Boyce, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of LifeBryan S Nelson, Camlin Tierney, Deborah Persaud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2019
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency VirusMichael J Boivin, Miriam Chernoff, Lee Fairlie, et al.
The Journal of Infectious Diseases|February 2, 2020
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The New England Journal of Medicine|October 15, 2010
Antiretroviral treatment for children with peripartum nevirapine exposurePaul Palumbo, Jane C Lindsey, Michael D Hughes, et al.
Lancet (London, England)|November 12, 2013
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trialMark F Cotton, Avy Violari, Kennedy Otwombe, et al.
Science Translational Medicine|November 29, 2019
Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profilePilar Garcia-Broncano, Shivaali Maddali, Kevin B Einkauf, et al.
The American Journal of Tropical Medicine and Hygiene|November 23, 2017
Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral TherapyCharlotte V Hobbs, Erin E Gabriel, Portia Kamthunzi, et al.
Pageof 9